Continuous performance tests were found to be clinically useful when rating scales were inconclusive.ĭespite extensive research on attention deficit hyperactivity disorder (ADHD), and despite existing guidelines on the condition, there are still uncertainties regarding the clinical utility of different ADHD assessment methods and how a clinician should incorporate multiple informants, multiple methods, co-occurring symptoms and functional impairment in the diagnostic process (Jarrett, Van Meter, Youngstrom, Hilton & Ollendick, 2016). QbTest proved useful in titration of central stimulant treatment when parent ratings were inconclusive. Conners’ CPT II, but not QbTest, had incremental clinical utility in diagnostic assessment of children with ADHD when teacher and parent ratings were inconclusive. Dose titrations of central stimulants in 56 children with ADHD were evaluated using QbTest and the Swanson, Nolan, Pelham, version IV (SNAP-IV) scale.
The diagnostic clinical utility of Conners’ CPT II and QbTest was analysed using receiver operator characteristics (ROC) and post-test probability in 80 children with and 38 without ADHD. Retrospective data from child and adolescent psychiatric records of two populations were studied.
This study aimed to examine the incremental clinical utility of Conners’ continuous performance test (CPT) II and QbTest in diagnostic assessments and treatment monitoring of attention deficit hyperactivity disorder (ADHD). Despite extensive research on attention deficit hyperactivity disorder (ADHD), there are still uncertainties regarding the clinical utility of different ADHD assessment methods.
0 kommentar(er)
